Dr. Megan Weivoda is an Assistant Professor in the Department of Periodontics and Oral Medicine at the University of Michigan. She received her Ph.D. in Pharmacology at the University of Iowa and performed a visiting fellowship at the University of Oxford and postdoctoral research at the Mayo Clinic. Dr. Weivoda previously served as Assistant Professor in the Division of Endocrinology at the Mayo Clinic.
Dr. Weivoda’s research program focuses on the role of osteoclasts in the bone remodeling cycle. Specifically, she is investigating the mechanisms by which osteoclast-mediated bone resorption activates subsequent cycles of bone formation and how this “coupling” is disrupted during aging in order to identify novel mechanisms to stimulate bone formation. Dr. Weivoda is a member of the American Society for Bone and Mineral Research (ASBMR) and currently serves on the ASBMR Early Stage Investigator Subcommittee.
Weivoda, M.M., Xu, M., Pirtskhalava, T., et al. (2018). “Senolytics improve physical function and increase lifespan in old age.” Nature Medicine. 24(8). pp. 1246-1256.
Weivoda, M.M., Farr, J.N., Nicks, K.M., et al. (2018). “Osteoprotection Through the Deletion of the Transcription Factor Rorβ in Mice.” Journal of Bone and Mineral Research. 33(4). pp. 720-731.
Farr, J.N., Xu, M., Weivoda, M.M., et al. (2017). “Targeting cellular senescence prevents age-related bone loss in mice.” Nature Medicine. 23(9). pp. 1072-1079.
Xu, M., Bradley, E.W., Weivoda, M.M., et al. (2017). “Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice.” The journals of gerontology. Series A, Biological sciences and medical sciences. 72(6). pp. 780-785.
Weivoda, M.M., Youssef, S.J,., Oursler, M.J. (2017). “Sclerostin expression and functions beyond the osteocyte.” Bone. 96. Pp. 45-50.